Surprisingly, we have observed the highest levels of IL-6 expression in group A of the COPD patients according to the GOLD classification, therefore in subjects with fewer symptoms and low risk of future exacerbations. This evidence concerns the gene IL6 and chronic obstructive pulmonary disease.